2159.HK

Mediwelcome Announced 2022 Interim Results

Retrieved on: 
星期五, 九月 23, 2022

HONG KONG, Sept 23, 2022 - (ACN Newswire) - A China's leading provider of digital medical service solutions - Mediwelcome Healthcare Management & Technology Inc. ("Mediwelcome" or the "Company", and together with its subsidiaries, the "Group") (Stock Code: 2159), announced the unaudited consolidated interim results for the six months ended 30 June 2022 (the "Reporting Period" or the "First half of 2022").

Key Points: 
  • HONG KONG, Sept 23, 2022 - (ACN Newswire) - A China's leading provider of digital medical service solutions - Mediwelcome Healthcare Management & Technology Inc. ("Mediwelcome" or the "Company", and together with its subsidiaries, the "Group") (Stock Code: 2159), announced the unaudited consolidated interim results for the six months ended 30 June 2022 (the "Reporting Period" or the "First half of 2022").
  • In the first half of 2022, Mediwelcome has narrowed in revenue and other aspects to varying degrees due to the continuous lockdown in many provinces in response to the severe pandemic in the PRC.
  • In the first half of 2022, Mediwelcome's revenue decreased by approximately 49.2% to approximately RMB172.5 million YoY.
  • To strengthen the Group's conference management capabilities, Mediwelcome has launched the Conference+ App for medical NGOs and pharmaceutical companies to submit onsite conference requests and monitor conference implementation.